Anixa Biosciences
ANIX
ANIX
41 hedge funds and large institutions have $9.05M invested in Anixa Biosciences in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $10.2M → $9.05M (-$1.16M)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
41
Holding in Top 10
–
Calls
$78K
Puts
$5K
Top Buyers
| 1 | +$259K | |
| 2 | +$44K | |
| 3 | +$42K | |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
+$35.9K |
| 5 |
Morgan Stanley
New York
|
+$34.5K |
Top Sellers
| 1 | -$291K | |
| 2 | -$108K | |
| 3 | -$104K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$101K |
| 5 |
VF
Virtu Financial
New York
|
-$84K |